Cyclacel Pharmaceuticals, Inc. - CYCC Korxona qiymatining sotuvga nisbati

cyclacel.com (CYCC) kompaniyasining rasmiy ramzlari

Cyclacel Pharmaceuticals (CYCC) kompaniyasining muvaffaqiyati leykozni davolashda CDK inhibitorlarining samaradorligiga va nojo'ya ta'sirlarning yo'qligiga bog'liq. Korxona qiymatining daromadga nisbati multiplikator dinamikasini namoyish etadi, bunda qiymati joriy ko'rsatkichni ifodalaydi. Fadraziclib bo'yicha ma'lumotlar va mutatsiyalarga aniqlik bilan yondashuv o'sishni ta'minlasa-da, savdolarning yo'qligi kapitalizatsiyani sinov natijalariga bog'liq qiladi.

Cyclacel, Inc. (CYCC): Kompaniya qiymatining daromadga nisbati 04.07.2022dan 20.11.2026gacha

Cyclacel Pharmaceuticals Inc. - tahliliy kesimlar va asosiy koʻrsatkichlar (CYCC)

Kompaniyaning fundamental baholanishi:CYCC, cyclacel.com
Cyclacel Pharmaceuticals, Inc. tomonidan chiqariladigan mahsulotlar

Ushbu ko'rsatkich korxona qiymatidan sof qarzi ayirib tashlangan holda savdo hajmi bilan nisbatda o'lchaydi, bu esa moliyaviy leverajdan qat'i nazar aktivning premiumini aniqlash imkonini beradi. GURU.Markets platformasida qarzlarsiz tushumlar asosidagi baholashni tahlil qilish orqali, investor saratonga qarshi dori vositalari uchun qimmat klinika sinovlari sharoitida Cyclacel Pharmaceuticals (CYCC) kapitalizatsiyasining intellektual patentlari bilan qanchalik asoslanganligini baholashi mumkin.

Raqobatchilar tahlili

Korxona qiymati/daromad multiplikatori Incyte Corporation|HCM (HUTCHMED Corp) - Kompaniya qiymatining daromadga nisbati|Korxona qiymatining sotuvga nisbati Nuvation Pharma NUVB|Kompaniya qiymatining daromadga nisbati DAWN|Korxona qiymati/daromad multiplikatori Monopar Therapeutics MNPR|Kompaniya qiymatining daromadga nisbati INBX (Inhibrx Biosciences)|IMAB (I-Mab Inc.) - Biznes qiymatining daromadga nisbati|Fennec Pharmaceuticals - Kompaniya qiymatining daromadga nisbati|Korxona qiymati/daromad koeffitsiyenti HRTX (Heron Therapeutics Inc)|Nuvectis - EV/Sales multiplikatori|Biznes qiymatining daromadga nisbati CHRS (Coherus BioSciences Inc.)|CRBP: EV/Sales multiplikatori|Korxona qiymati/daromad multiplikatori Cardiff Oncology Corp (CRDF)|Korxona qiymatining daromadga nisbati BeyondSpring|BCAB: Biznes qiymatining daromadga nisbati|EV/Sales multiplikatori LIXT|EV/Sales multiplikatori Citius Pharmaceuticals Inc. (CTXR)|Korxona qiymatining daromadga nisbati Cellectar CLRB|BLRX (BioLineRx) - Korxona qiymatining sotish hajmiga nisbati|CANF: Kompaniya qiymatining daromadga nisbati|Korxona qiymati/daromad multiplikatori aprea.com|Kazia Therapeutics Limited (KZIA) - Korxona qiymatining daromadga nisbati|SLXN - Kompaniya umumiy qiymatining daromadga nisbati|Kompaniya qiymatining daromadga nisbati NCNA|CMRX: Biznes qiymatining daromadga nisbati|G1 Therapeutics Inc. (GTHX) - Biznes qiymatining daromadga nisbati|KRON - Korxona qiymati/daromad multiplikatori|Kintara Therapeutics, Inc. - Kompaniya qiymatining daromadga nisbati|Korxona qiymati/daromad koeffitsiyenti ONCT (Oncternal)|Portage Biotech Corp - EV/Sales multiplikatori